Size Matters: Sequential Mutations in Tumorigenesis May Reflect the Stochastic Effect of Mutagen Target Sizes

Genes and Cancer

Volumn 2, Issue 10, 2011, Pages 927-931

  Long, Kimberly ^a   Abuelenen, Toaa ^a   Pava, Libia ^a   Bastille, Maya ^a   Blanck, George ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

metastasis suppressor proteins; sequential cancer mutations; tumor suppressor proteins

Indexed keywords

MUTANT PROTEIN; TUMOR SUPPRESSOR PROTEIN;

CANCER GENETICS; CARCINOGENESIS; GENE MUTATION; GENOME ANALYSIS; GENOME SIZE; HUMAN; MOLECULAR WEIGHT; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REVIEW; TUMOR GENE;

EID: 84868652210     PISSN: 19476019     EISSN: 19476027     Source Type: Journal    
DOI: 10.1177/1947601911436200     Document Type: Review

References (32)

1. Fearon ER,Vogelstein B.A genetic model for colorectal tumorigenesis.Cell. 1990;61:759-67.
2. Hisamuddin IM,Yang VW.Molecular genetics of colorectal cancer: an overview.Curr Colorectal Cancer Rep. 2006;2:53-9.
3. Hanahan D,Weinberg RA.Hallmarks of cancer: the next generation.Cell. 2011;144:646-74.
4. Harada H,Kitagawa M,Tanaka N, et al.Anti-oncogenic and oncogenic potentials of interferon regulatory factors-1 and -2.Science. 1993;259:971-4.
5. Lu Y,Ussery GD,Muncaster MM,Gallie BL,Blanck G.Evidence for retinoblastoma protein (RB) dependent and independent IFN-gamma responses: RB coordinately rescues IFN-gamma induction of MHC class II gene transcription in noninducible breast carcinoma cells.Oncogene. 1994;9:1015-9.
6. Kadota M,Yang HH,Gomez B, et al.Delineating genetic alterations for tumor progression in the MCF10A series of breast cancer cell lines.PLoS One. 2010;5:e9201.
7. Noguchi M.Stepwise progression of pulmonary adenocarcinoma: clinical and molecular implications.Cancer Metastasis Rev. 2010;29:15-21.
8. Jimenez RE,Warshaw AL,Z'graggen K, et al.Sequential accumulation of K-ras mutations and p53 overexpression in the progression of pancreatic mucinous cystic neoplasms to malignancy.Ann Surg. 1999;230:501-9.
9. Iiizumi M,Liu W,Pai SK,Furuta E,Watabe K.Drug development against metastasis-related genes and their pathways: a rationale for cancer therapy.Biochim Biophys Acta. 2008;1786:87-104.
10. Horak CE,Lee JH,Marshall JC,Shreeve SM,Steeg PS.The role of metastasis suppressor genes in metastatic dormancy.APMIS. 2008;116:586-601.
11. Berger JC,Vander Griend DJ,Robinson VL,Hickson JA,Rinker-Schaeffer CW.Metastasis suppressor genes: from gene identification to protein function and regulation.Cancer Biol Ther. 2005;4:805-12.
12. Smith SC,Theodorescu D.Learning therapeutic lessons from metastasis suppressor proteins.Nat Rev Cancer. 2009;9:253-64.
13. McCawley LJ,Li S,Wattenberg EV,Hudson LG.Sustained activation of the mitogen-activated protein kinase pathway: a mechanism underlying receptor tyrosine kinase specificity for matrix metalloproteinase-9 induction and cell migration.J Biol Chem. 1999;274:4347-53.
14. Eason DD,Blanck G.High level class II trans-activator induction does not occur with transient activation of the IFN-gamma signaling pathway.J Immunol. 2001;166:1041-8.
15. Edwards LJ,Evavold BD.T cell recognition of weak ligands: roles of signaling, receptor number, and affinity.Immunol Res. 2011;50:39-48.
16. Ma Y,Ma L,Guo Q,Zhang S.Expression of bone morphogenetic protein-2 and its receptors in epithelial ovarian cancer and their influence on the prognosis of ovarian cancer patients.J Exp Clin Cancer Res. 2010;29:85.
17. Li J,Cheng Y,Tai D,Martinka M,Welch DR,Li G.Prognostic significance of BRMS1 expression in human melanoma and its role in tumor angiogenesis.Oncogene. 2011;30:896-906.
18. Goldberg SF,Miele ME,Hatta N, et al.Melanoma metastasis suppression by chromosome 6: evidence for a pathway regulated by CRSP3 and TXNIP.Cancer Res. 2003;63:432-40.
19. Zhang T,Zheng J,Liu C,Lu Y.Expression of DLC-1 in clear cell renal cell carcinoma: prognostic significance for progression and metastasis.Urol Int. 2009;82:380-7.
20. Dai C,Dong QZ,Ren N, et al.Downregulation of HTPAP transcript variant 1 correlates with tumor metastasis and poor survival in patients with hepatocellular carcinoma.Cancer Sci. 2011;102:583-90.
21. Yang X,Welch DR,Phillips KK,Weissman BE,Wei LL.KAI1, a putative marker for metastatic potential in human breast cancer.Cancer Lett. 1997;119:149-55.
22. Zheng S,Chang Y,Hodges KB, et al.Expression of KISS1 and MMP-9 in non-small cell lung cancer and their relations to metastasis and survival.Anticancer Res. 2010;30:713-8.
23. Chen Y,Yusenko MV,Kovacs G.Lack of KISS1R expression is associated with rapid progression of conventional renal cell carcinomas.J Pathol. 2011;223:46-53.
24. Ishikawa M,Nakayama K,Rahman MT, et al.Functional and clinicopathological analysis of loss of MKK4 expression in endometrial cancer.Oncology. 2010;79:238-46.
25. Friess H,Guo XZ,Tempia-Caliera AA, et al.Differential expression of metastasis-associated genes in papilla of vater and pancreatic cancer correlates with disease stage.J Clin Oncol. 2001;19:2422-32.
26. LaTulippe E,Satagopan J,Smith A, et al.Comprehensive gene expression analysis of prostate cancer reveals distinct transcriptional programs associated with metastatic disease.Cancer Res. 2002;62:4499-506.
27. Zhang B,Zhang J,Xu ZY,Xie HL.Expression of RECK and matrix metalloproteinase-2 in ameloblastoma.BMC Cancer. 2009;9:427.
28. Gimenez M,Souza VC,Izumi C, et al.Proteomic analysis of low- to high-grade astrocytomas reveals an alteration of the expression level of raf kinase inhibitor protein and nucleophosmin.Proteomics. 2010;10:2812-21.
29. Baraniskin A,Munding J,Schulmann K, et al.Prognostic value of reduced SMAD4 expression in patients with metastatic colorectal cancer under oxaliplatin-containing chemotherapy: a translational study of the AIO colorectal study group.Clin Colorectal Cancer. 2011;10:24-9.
30. Wang P,Fan J,Chen Z, et al.Low-level expression of Smad7 correlates with lymph node metastasis and poor prognosis in patients with pancreatic cancer.Ann Surg Oncol. 2009;16:826-35.
31. Xia W,Unger P,Miller L,Nelson J,Gelman IH.The Src-suppressed C kinase substrate, SSeCKS, is a potential metastasis inhibitor in prostate cancer.Cancer Res. 2001;61:5644-51.
32. Tome ME,Johnson DB,Rimsza LM, et al.A redox signature score identifies diffuse large B-cell lymphoma patients with a poor prognosis.Blood. 2005;106:3594-601.